Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
04/06/1995 | CA2172601A1 Perfluorocarbons as anti-inflammatory agents |
04/06/1995 | CA2167526A1 Monoglyceride/lactate ester permeation enhancer |
04/06/1995 | CA2165802A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
04/06/1995 | CA2133614A1 Retinol containing anhydrous and stable cosmetic or pharmaceutical composition for skin and use thereof for the treatment of skin diseases |
04/05/1995 | EP0646593A1 Corticoid-17,21-dicarboxylic acid ester and corticosteroid-17-carboxylic acid ester-21-carbonic, process for their production and medicaments containing them |
04/05/1995 | EP0646576A1 Vitamin D3-analogs |
04/05/1995 | EP0646371A1 Anhydrous cosmetic or pharmaceutical composition containing retinol |
04/05/1995 | EP0646012A1 Wound healing and treatment of fibrotic disorders |
03/30/1995 | WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
03/30/1995 | WO1995008565A1 Use of angiotensin ii analogs in tissue repair |
03/30/1995 | WO1995008555A1 2',5'-oligoadenylate-2',3'-cyclophosphates |
03/30/1995 | WO1995008535A1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
03/30/1995 | WO1995008338A1 Method for the treatment or prevention of eczema/dermatitis |
03/30/1995 | WO1995008337A1 Use of angiotensin iii and analogs thereof in tissue repair |
03/30/1995 | WO1995008325A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease |
03/30/1995 | CA2172605A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease |
03/30/1995 | CA2172494A1 Use of angiotensin ii analogs in tissue repair |
03/30/1995 | CA2172491A1 Method for the treatment or prevention of eczema/dermatitis |
03/30/1995 | CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
03/29/1995 | EP0645141A1 Treating water for dermatoses in domestic animals |
03/29/1995 | EP0644766A1 Nitrous oxide containing dermatological composition |
03/29/1995 | EP0644764A1 Lipids for epidermal moisturization and repair of barrier function |
03/29/1995 | EP0644716A1 Medical uses of trioxolane and diperoxide compounds |
03/28/1995 | US5401777 Use of preparations of curcuma plants |
03/28/1995 | US5401773 Treating comedones |
03/28/1995 | US5401770 Antipruritic agents and antipruritic compositions thereof |
03/28/1995 | US5401733 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol |
03/28/1995 | US5401517 Cosmetic method for treatment of skin |
03/28/1995 | CA1334936C Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
03/23/1995 | WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine |
03/23/1995 | WO1995007710A1 Remedy for wound |
03/23/1995 | WO1995007692A1 Viscous surfactant emulsion compositions |
03/23/1995 | WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
03/23/1995 | WO1994028897A3 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
03/23/1995 | CA2149323A1 Therapeutic agent for treating wounds |
03/22/1995 | EP0643959A1 Use of 13-transretinoic acid esters for the treatment of skin cancer and photoaging |
03/22/1995 | EP0643712A1 Spiro-oxetanes, process for preparing the same and medicaments |
03/22/1995 | EP0557301B1 5-fluoro-2,4,6-pyrimidinetriamine compounds for preventing hair loss |
03/21/1995 | US5399698 Quinolin-2-yl-methoxybenzylhydroxyureas |
03/21/1995 | US5399694 Antitumor |
03/21/1995 | US5399590 Treatment of skin tumors, rheumatic diseases |
03/21/1995 | US5399563 Benzylidenequinuclidinones |
03/21/1995 | US5399561 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity |
03/21/1995 | CA1334850C Ureylene-2,4,6-pyrimidine-3-oxide derivatives, their preparation and use in cosmetics and dermopharmacy |
03/21/1995 | CA1334847C Oxadiazolopyrimidones, their preparation and application in cosmetics and dermopharmacy |
03/16/1995 | WO1995007091A1 Uses of vegetable oils |
03/16/1995 | WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
03/15/1995 | EP0642516A1 Macrocyclic immunomodulators |
03/15/1995 | EP0642513A1 Indolocarbazole imides and their use |
03/15/1995 | EP0642499A1 Retinoids and their use in treating skin diseases and leukemia |
03/15/1995 | EP0642351A1 New pharmaceutical uses of krill enzymes |
03/15/1995 | EP0642346A1 Solid, storage-stable, germicidal, pre-iodine composition |
03/15/1995 | EP0558509B1 Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, dermatological compositions in particular, helping renew the epidermis, stimulating regrowth of hair, or delaying hair loss |
03/15/1995 | EP0394333B1 Uses of sulphated sugars |
03/15/1995 | CN1099982A Medicine for treatment of leukoderma and its preparing method |
03/14/1995 | US5397775 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same |
03/14/1995 | CA1334759C N,n'-diaminocarbonylmethyl-n,n'-dicarboxymethyl-1,2- diaminoethane derivatives |
03/14/1995 | CA1334751C Ureylene-2,4,6-pyrimidine-3-oxide derivatives, their preparation and use in cosmetics and dermopharmacy |
03/09/1995 | WO1995006457A1 Compositions against skin impurities and mild forms of acne containing lanolinic acid or lanolinic acid components as active substance |
03/08/1995 | EP0641759A1 Aromatic carboxylic acid derivatives, their preparation and drugs containing these derivatives |
03/08/1995 | EP0641557A1 Dermatologic or cosmetic composition made up by an oil in water emulsion based on oily globules coated with a lamellar liquid crystall coating |
03/08/1995 | EP0641223A1 Biotherapeutic cell-coated microspheres |
03/08/1995 | EP0641201A1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids |
03/08/1995 | CN1099604A Hair lotion |
03/07/1995 | US5395842 Inhibitors of sex steroids |
03/07/1995 | US5395624 Depigmenting cosmetic and/or dermatological composition containing a di- or tri-caffeoylquinic acid, or a mixture thereof |
03/07/1995 | CA1334656C Esterified oligosaccharides having uronic acid and hexosamine residues |
03/02/1995 | WO1995006020A1 New diphenylhexene |
03/02/1995 | WO1995005852A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections |
03/02/1995 | WO1995005829A1 Therapeutic system for treating psoriasis |
03/02/1995 | CA2168882A1 Therapeutic system for treating psoriasis |
03/01/1995 | EP0640616A2 17-Alkylcarbonate, 21-0-carbonic/carboxylic acid esters of corticosteroids, a method for their production and pharmaceutical compositions containing them |
03/01/1995 | EP0640352A1 Preparation of a skin surface for a surgical procedure |
03/01/1995 | EP0640346A1 Uses of sulphated sugars against inflammation |
03/01/1995 | EP0640342A2 Pentoxifylline and/or depogen for improving the tissue antioxidant status |
03/01/1995 | EP0640340A1 Composition for accelerating healing of wound |
03/01/1995 | EP0640129A1 Inhibition of cell adhesion protein-carbohydrate interactions |
03/01/1995 | EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
03/01/1995 | CN1099265A Composition for accelerating healing of wound |
03/01/1995 | CA2131224A1 Treating water for dermatoses in domestic animals |
02/28/1995 | US5393900 Steroid intermediates for the formation of vitamin D3 analogues |
02/28/1995 | US5393792 High dosage topical forms of collagenase |
02/28/1995 | US5393788 Administering in the treatment of asthma or an allergic or inflammatory disease |
02/28/1995 | US5392725 Sewing machine needle and method for manufacturing same |
02/28/1995 | CA2130015A1 Preparation of a skin surface for a surgical procedure |
02/28/1995 | CA2028560C Methods and compositions employing certain lysozymes and endoglycosidases |
02/23/1995 | WO1995005412A1 Cosmetic melanins |
02/23/1995 | WO1995005375A1 Indole derivatives as 5-alpha-reductase-1-inhibitors |
02/23/1995 | WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY |
02/23/1995 | WO1995005155A1 Use of oligosaccharides for the prevention and treatment of tissue ageing |
02/23/1995 | CA2590837A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity |
02/23/1995 | CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity |
02/22/1995 | EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production |
02/22/1995 | EP0639373A1 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds |
02/22/1995 | EP0639368A1 Scalp care product composition |
02/22/1995 | EP0639224A1 Lectin domain variants of selectin |
02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
02/22/1995 | EP0639073A1 Biologically active ureido derivatives useful as antimetastatic agents |
02/22/1995 | EP0639068A1 Acne treating composition |
02/22/1995 | EP0526502B1 Phenolic amine depigmenting and antimelanoma agents |